Terms: = Bone cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Prognosis
1323 results:
1. The Evaluation and Management of Lung Metastases in Patients with Giant Cell Tumors of bone in the Denosumab Era.
Trovarelli G; Rizzo A; Cerchiaro M; Pala E; Angelini A; Ruggieri P
Curr Oncol; 2024 Apr; 31(4):2158-2171. PubMed ID: 38668063
[TBL] [Abstract] [Full Text] [Related]
2. [Analysis of factors influencing the efficacy and prognosis of surgical treatment for primary malignant pelvic bone tumors].
Liu WF; Hao L; Li ZY; Jin T; Sun Y; Yang YK; Li Y; Yang FJ; Yu F; Zhang Q; Niu XH
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):344-353. PubMed ID: 38644270
[No Abstract] [Full Text] [Related]
3. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057
[TBL] [Abstract] [Full Text] [Related]
4. Acute Lymphoblastic Leukemia With Near-haploid Karyotype and Philadelphia Chromosome.
Panagopoulos I; Andersen K; Wik HS; Tandsæther MR
Anticancer Res; 2024 Apr; 44(4):1389-1397. PubMed ID: 38537997
[TBL] [Abstract] [Full Text] [Related]
5. [Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation in the treatment of secondary acute myeloid leukemia].
Yuan XL; Wu YB; Song XL; Chen Y; Lu Y; Lai XY; Shi JM; Liu LZ; Zhao YM; Yu J; Yang LX; Lan JP; Cai Z; Huang H; Luo Y
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):41-47. PubMed ID: 38527837
[No Abstract] [Full Text] [Related]
6. Prognostic and clinicopathological significance of the Controlling Nutritional Status (CONUT) score in patients with lymphoma: a meta-analysis.
Li L; Shou L
BMJ Open; 2024 Mar; 14(3):e078320. PubMed ID: 38453197
[TBL] [Abstract] [Full Text] [Related]
7. [Importance of Secondary cancer Screening-In the Case of Childhood cancer].
Ishida Y
Gan To Kagaku Ryoho; 2024 Feb; 51(2):119-124. PubMed ID: 38449394
[TBL] [Abstract] [Full Text] [Related]
8. Natural history of bone-only metastasis in renal cell carcinoma.
Tang B; Duan R; Fan Z; Yan X; Li S; Zhou L; Li J; Xu H; Mao L; Lian B; Wang X; Bai X; Wei X; Li C; Cui C; Si L; Chi Z; Guo J; Sheng X
Urol Oncol; 2024 Apr; 42(4):119.e17-119.e22. PubMed ID: 38383241
[TBL] [Abstract] [Full Text] [Related]
9. Integrated transcriptomic analysis systematically reveals the heterogeneity and molecular characterization of cancer-associated fibroblasts in osteosarcoma.
Liu Y; Han X; Han Y; Bi J; Wu Y; Xiang D; Zhang Y; Bi W; Xu M; Li J
Gene; 2024 May; 907():148286. PubMed ID: 38367852
[TBL] [Abstract] [Full Text] [Related]
10. bone marrow metastasis in nonhematological malignancies: A study from tertiary care center.
Singh A; Rawat S; Kushwaha R; Jain M; Verma SP; Verma N; Singh US
Ann Afr Med; 2024; 23(1):91-99. PubMed ID: 38358178
[TBL] [Abstract] [Full Text] [Related]
11. Exploring risk factors and molecular targets in leukemia patients with COVID-19: a bioinformatics analysis of differential gene expression.
Ullah MA; Moin AT; Nipa JF; Islam NN; Johora FT; Chowdhury RH; Islam S
J Leukoc Biol; 2024 Mar; 115(4):723-737. PubMed ID: 38323674
[TBL] [Abstract] [Full Text] [Related]
12. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
[TBL] [Abstract] [Full Text] [Related]
13. Copy Number Gain in Androgen Receptors Predicts the Poor prognosis in Japanese Castration-resistant Prostate cancer.
Sakamoto S; Ando K; Pae S; Zhao X; Sakai K; Sato K; Saito S; Yamada Y; Rii J; Goto Y; Sazuka T; Imamura Y; Anzai N; Akakura K; Nishio K; Ichikawa T
Anticancer Res; 2024 Feb; 44(2):639-647. PubMed ID: 38307556
[TBL] [Abstract] [Full Text] [Related]
14. A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
Tsukamoto S; Mavrogenis AF; Nitta Y; Righi A; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
Curr Oncol; 2024 Jan; 31(1):566-578. PubMed ID: 38275833
[TBL] [Abstract] [Full Text] [Related]
15. The poor prognosis of lacrimal gland adenocarcinoma: a clinical study and literature review.
Liu R; Ren T; Li J; Wang N; Xu L; Guo Q; Zhang H; Ma J
J Cancer Res Clin Oncol; 2024 Jan; 150(1):26. PubMed ID: 38263473
[TBL] [Abstract] [Full Text] [Related]
16. Case Report: A novel mixture of dose-fractioned radiation and immunotherapy for treatment of cholangiocarcinoma.
Wang N; Wang L; Huang A; Han J; Cao T; Mei X; Yao J; Xiao Y; Ma H
Front Immunol; 2023; 14():1273962. PubMed ID: 38162668
[TBL] [Abstract] [Full Text] [Related]
17. Machine learning-based detection of sarcopenic obesity and association with adverse outcomes in patients undergoing surgical treatment for spinal metastases.
Khalid SI; Massaad E; Kiapour A; Bridge CP; Rigney G; Burrows A; Shim J; De la Garza Ramos R; Tobert DG; Schoenfeld AJ; Williamson T; Shankar GM; Shin JH
J Neurosurg Spine; 2024 Mar; 40(3):291-300. PubMed ID: 38039533
[TBL] [Abstract] [Full Text] [Related]
18. Immunophenotypic portrait of leukemia-associated-phenotype markers in B acute lymphoblastic leukemia.
Boris E; Theron A; Montagnon V; Rouquier N; Almeras M; Moreaux J; Bret C
Cytometry B Clin Cytom; 2024 Jan; 106(1):45-57. PubMed ID: 38037221
[TBL] [Abstract] [Full Text] [Related]
19. Effect of initial recurrence site on the prognosis of different tissue types of non-small cell lung cancer: a retrospective cohort study.
Li Y; Liu L; You R; Li Q; Jiang Z; Pu H; Li Z; Chen X
World J Surg Oncol; 2023 Nov; 21(1):360. PubMed ID: 37986082
[TBL] [Abstract] [Full Text] [Related]
20. Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: a multicenter study.
Isaka T; Adachi H; Murakami K; Miura J; Kikunishi N; Shigeta N; Kudo Y; Miyata Y; Okada M; Ikeda N; Ito H
BMC Cancer; 2023 Nov; 23(1):1064. PubMed ID: 37926846
[TBL] [Abstract] [Full Text] [Related]
[Next]
